Recent groundbreaking research published in Nature Microbiology has highlighted the significant role of Akkermansia muciniphila (Akk) in combating metabolic disorders.

In the world of probiotics, Akkermansia muciniphila is emerging as a revolutionary player with promising potential for enhancing gut health and aiding in weight management.

The patent describes the discovery and application of a specific strain of Limosilactobacillus reuteri (LR38), preserved under CGMCC No.24408, which is effective in improving polycystic ovary syndrome (PCOS).

Human-residential probiotics are beneficial microorganisms that naturally reside in the human body, particularly in the gut. They play a crucial role in maintaining health and well-being.

Weizmannia coagulans BC99​, a novel probiotic strain, has shown potential in treating gastrointestinal disorders, particularly chronic constipation.

This study explores the effects of Lacticaseibacillus paracasei LC86 on age-related declines in muscle strength and cognitive function in SAMP8 mice. Chronic inflammation and gut microbiota composition are key factors in these declines.